BiO2 Medical, Inc. is a medical device manufacturer founded to design, develop, and subsequently manufacture a range of medical products in response to clinical needs.
BiO2 Medical's current primary objective is to develop and commercialize the Angel™ Catheter as the de facto standard of care device for the prevention of Pulmonary Embolism related mortality and morbidity in critically ill patients worldwide.
This proven team of technical staff is supported by management and advisors who have worked together for 10 years and have extensive experience in: medical device development, product commercialization, and patent portfolio creation.
In July 2016, BiO2 Medical was granted FDA approval for the Angel Catheter; the only productapproved for the prevention of pulmonary embolism in hospitalized patients.
BiO2 Medical's current primary objective is to develop and commercialize the Angel™ Catheter as the de facto standard of care device for the prevention of Pulmonary Embolism related mortality and morbidity in critically ill patients worldwide.
This proven team of technical staff is supported by management and advisors who have worked together for 10 years and have extensive experience in: medical device development, product commercialization, and patent portfolio creation.
In July 2016, BiO2 Medical was granted FDA approval for the Angel Catheter; the only productapproved for the prevention of pulmonary embolism in hospitalized patients.
Location: United States, Texas, San Antonio
Employees: 11-50
Total raised: $46.7M
Founded date: 2006
Investors 1
| Date | Name | Website |
| - | Targeted T... | targetedte... |
Funding Rounds 5
| Date | Series | Amount | Investors |
| 30.08.2016 | - | $3M | - |
| 07.01.2016 | - | $14M | - |
| 10.07.2015 | - | $4M | - |
| 08.09.2012 | Series C | $12M | - |
| 26.03.2012 | Series B | $13.7M | - |
Mentions in press and media 14
| Date | Title | Description |
| 31.08.2016 | Ten Life Science Companies to Watch in San Antonio | By LAURA LOREK Reporter with Silicon Hills News |
| 30.08.2016 | Bio2 Medical Closes $3M Venture Debt Financing | Bio2 Medical, Inc., a Golden, CO-based developer of a catheter to protect critically ill patients from acute Pulmonary Embolism (PE), closed its $3m second tranche of venture debt funding. Oxford Finance provided the financing. The company ... |
| 07.01.2016 | Daily funding roundup - January 7, 2016 | Guardant Health raised $100M; Founders Fund invested $52M in NuBank; Sisense received $50M funding IQuity Labs, a Nashville, TN-basedbiotechnology company specializing in diagnostic tests for autoimmune disease and related conditions, secur... |
| 07.01.2016 | BiO2 Medical Raises $14M in Equity and Debt Financing | BiO2 Medical, Inc., a San Antonio, Texas-and Golden, CO-based a medical device manufacturer, raised approximately $14m in equity and debt financing. The financing included a $9m Series D funding round from unnamed backers and a $5m venture ... |
| 10.07.2015 | BiO2 Medical raises $4M for device that prevents embolism | Studying Brigham & Women’s Hospital over the course of eight years, the study found that “an average of 160 patients with pulmonary embolism were admitted each year, requiring an annual hospital expense ranging from $884,814 to $1,866,4... |
| 14.03.2014 | Catheter maker Bi02 Medical raises $6M | Bi02 Medical, maker of the Angel vena cava filter catheter, said it raised nearly $5.9 million in a hoped-for $7.5 million equity offering. The funding round for the San Antonio, Texas-based medical device company involved 10 unnamed invest... |
| 12.09.2012 | Fundraising: Startup aiming to prevent pulmonary embolisms raises $12M | Location: San Antonio, Texas. Solution/product: The Angel Catheter is a “central venous catheter and inferior vena cava (IVC) filter combination device” that is designed to prevent pulmonary embolism in critically ill patients. Money raised... |
| 08.09.2012 | BiO2 Medical Raises $12M in Series C Funding | BiO2 Medical, Inc., a San Antonio, Texas-based medical device manufacturer has raised $12m in Series C funding. The round was led by Remeditex Ventures, with participation from existing investors. The company intends to use the funding to c... |
| 06.08.2012 | Volcano lands tentative win in CardioSpectra lawsuit | Former shareholders of medical device company CardioSpectra, acquired by Volcano (NSDQ:VOLC) in 2007, have another 2 weeks to correct the defects in a lawsuit seeking some $17 million in milestone payments from Volcano. That San Diego-based... |
| 27.03.2012 | BiO2 Medical Secures $13.7M Series B | SAN ANTONIO, TX, Medical device manufacturer completed its $13.7M Series B round of funding, which included the conversion of a $1M State of Texas Emerging Technology Fund (ETF) award. The round was led by San Antonio's Targeted Technolog... |
Show more